| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,790,000 |
| Market
Cap: |
3.28(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$100.05 - $100.05 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Babler Martin |
President, CEO |
• • – |
2019-12-18 |
4 |
AS |
$52.77 |
$241,459 |
I/I |
(4,500) |
15,696 |
|
- |
|
| Babler Martin |
President, CEO |
• • – |
2019-12-17 |
4 |
AS |
$51.80 |
$1,323,995 |
I/I |
(25,000) |
54,179 |
|
- |
|
| Wolff Stefani |
Chief Development Officer |
• – – |
2019-12-16 |
4/A |
AS |
$49.29 |
$272,091 |
D/D |
(5,505) |
30,104 |
|
- |
|
| Wolff Stefani |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
AS |
$49.29 |
$272,091 |
D/D |
(5,505) |
35,609 |
|
- |
|
| Wolff Stefani |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
OE |
$4.54 |
$25,004 |
D/D |
5,505 |
41,114 |
|
- |
|
| Hardiman Roy C. |
Chief Business Officer |
• – – |
2019-12-13 |
4 |
AS |
$49.20 |
$247,034 |
D/D |
(5,000) |
120,143 |
|
- |
|
| Hardiman Roy C. |
Chief Business Officer |
• – – |
2019-12-13 |
4 |
OE |
$4.72 |
$24,743 |
D/D |
5,000 |
125,143 |
|
- |
|
| Becker Daniel J. |
Director |
– • – |
2019-11-20 |
4 |
B |
$29.94 |
$1,646,700 |
I/I |
55,000 |
667,600 |
2.1 |
- |
|
| Goldstein David |
Chief Scientific Officer |
• – – |
2019-11-07 |
4 |
AS |
$32.39 |
$323,914 |
D/D |
(10,000) |
29,819 |
|
- |
|
| Goldstein David |
Chief Scientific Officer |
• – – |
2019-11-07 |
4 |
OE |
$0.64 |
$18,815 |
D/D |
10,000 |
39,819 |
|
- |
|
| Becker Daniel J. |
Director |
– • – |
2019-10-29 |
4 |
B |
$33.98 |
$312,477 |
I/I |
9,196 |
612,600 |
2.1 |
- |
|
| Becker Daniel J. |
Director |
– • – |
2019-10-28 |
4 |
B |
$33.41 |
$2,285,549 |
I/I |
68,404 |
603,404 |
2.1 |
- |
|
| Glaxosmithkline Plc |
Former 10% Owner |
– – – |
2019-10-18 |
4 |
B |
$28.00 |
$9,999,976 |
I/I |
357,142 |
2,982,855 |
0.01 |
- |
|
| Becker Daniel J. |
Director |
– • – |
2019-10-18 |
4 |
B |
$28.00 |
$14,980,000 |
I/I |
535,000 |
535,000 |
2.1 |
- |
|
| George Simeon |
Director |
– • – |
2019-10-18 |
4 |
B |
$28.00 |
$9,999,976 |
I/I |
357,142 |
2,982,855 |
2.1 |
- |
|
| New Leaf Bpo Management Ii, L.l.c |
10% Owner |
– – • |
2019-08-13 |
4 |
S |
$35.00 |
$10,500,000 |
I/I |
(300,000) |
387,546 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2019-05-21 |
4 |
S |
$30.25 |
$30,250,000 |
I/I |
(1,000,000) |
1,605,713 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-09-18 |
4 |
B |
$17.00 |
$2,975,000 |
I/I |
175,000 |
383,480 |
2.1 |
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
208,480 |
208,480 |
|
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2018-09-18 |
4 |
B |
$17.00 |
$4,590,000 |
I/I |
270,000 |
2,625,713 |
1.5 |
- |
|
| Glaxosmithkline Plc |
10% Owner |
– – • |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,355,713 |
2,355,713 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-09-18 |
4 |
B |
$17.00 |
$4,250,000 |
I/I |
250,000 |
2,605,713 |
1.5 |
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,355,713 |
2,355,713 |
|
- |
|
| Becker Daniel J. |
Director |
– • • |
2018-09-18 |
4 |
B |
$17.00 |
$4,590,000 |
I/I |
270,000 |
437,537 |
2.25 |
- |
|
| Becker Daniel J. |
Director |
– • • |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,355,713 |
167,537 |
|
- |
|
83 Records found
|
|
Page 3 of 4 |
|
|
